Refreshing results…
Nivolumab and ipilimumab in recurrent or refractory cancer of unknown primary: a phase II trial
Download from doi.org5-Azacytidine modulates CpG methylation levels of EZH2 and NOTCH1 in myelodysplastic syndromes
Download from link.springer.comMissing publications? Search for publications with a matching author name.